Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239962

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239962

APAC Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Asia-Pacific transfection reagent and equipment market is projected to register a substantial CAGR of 10.7% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030

Some of the drivers that boost transfection reagents and equipment market's growth are as follows:

The increasing occurrence of chronic diseases, large- scale transfections used in clinical research

Development of synthetic biology products

Market Players:

Some of the major players operating in the Asia-Pacific transfection reagents and equipment market are:

Mirus Bio LLC.

Promega Corporation

Bio-Rad Laboratories, Inc.

Merck KGaA

Lonza

MaxCyte, Inc.

SBS Genetech

Cytiva

R&D Systems, Inc.

Takara Bio Inc.

Thermofisher Scientific Inc.

Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd),

OriGene Technologies, Inc.

Beckman Coulter, Inc. (A Subsidiary of Danaher)

SignaGen Laboratories

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 OVERVIEW OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET 18
  • 1.4 LIMITATIONS 22
  • 1.5 MARKETS COVERED 22

2 MARKET SEGMENTATION 28

  • 2.1 MARKETS COVERED 28
  • 2.2 GEOGRAPHICAL SCOPE 29
  • 2.3 YEARS CONSIDERED FOR THE STUDY 30
  • 2.4 CURRENCY AND PRICING 30
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
  • 2.6 MULTIVARIATE MODELLING 34
  • 2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE 34
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
  • 2.9 DBMR MARKET POSITION GRID 36
  • 2.10 MARKET APPLICATION COVERAGE GRID 37
  • 2.11 VENDOR SHARE ANALYSIS 38
  • 2.12 SECONDARY SOURCES 39
  • 2.13 ASSUMPTIONS 39

3 EXECUTIVE SUMMARY 40

4 PREMIUM INSIGHT 43

  • 4.1 PESTEL 44
  • 4.2 PORTER'S FIVE FORCES MODEL 45

5 INDUSTRY INSIGHTS: 46

6 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS 47

  • 6.1 EUROPEAN UNION REGULATORY SCENARIO 47
  • 6.2 U.S. REGULATORY SCENARIO 48
  • 6.3 JAPAN REGULATORY SCENARIO 48
  • 6.4 CHINA REGULATORY SCENARIO 49

7 MARKET OVERVIEW 51

  • 7.1 DRIVERS 53
    • 7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES 53
    • 7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS 54
    • 7.1.3 GROWING DEMAND FOR CHIMERIC GENES 54
    • 7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH 55
    • 7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS 55
  • 7.2 RESTRAINTS 56
    • 7.2.1 HIGH COST OF TRANSFECTION PRODUCTS 56
    • 7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS 56
    • 7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE 57
  • 7.3 OPPORTUNITIES 57
    • 7.3.1 EXPLORATION OF EMERGING MARKET 57
    • 7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 58
    • 7.3.3 SURGING LEVEL OF INVESTMENT 59
  • 7.4 CHALLENGES 59
    • 7.4.1 LONG APPROVAL PROCEDURE 59
    • 7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION 60
    • 7.4.3 LACK OF TRAINED PROFESSIONALS 61

8 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS 62

  • 8.1 OVERVIEW 63
  • 8.2 REAGENTS & KITS 66
  • 8.3 INSTRUMENTS 67

9 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE 69

  • 9.1 OVERVIEW 70
  • 9.2 RESEARCH 73
  • 9.3 PRECLINICAL 73
  • 9.4 CLINICAL PHASES 74
  • 9.5 COMMERCIAL 75

10 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE 77

  • 10.1 OVERVIEW 78
  • 10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT 81
  • 10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT 81

11 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS 83

  • 11.1 OVERVIEW 84
  • 11.2 NON-VIRAL METHODS 87
  • 11.3 VIRAL METHODS 87

12 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE 89

  • 12.1 OVERVIEW 90
  • 12.2 PLASMID DNA 92
  • 12.3 SMALL INTERFERING RNA (SIRNA) 93
  • 12.4 PROTEINS 94
  • 12.5 DNA OLIGONUCLEOTIDES 95
  • 12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS) 96
  • 12.7 OTHERS 96

13 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM 98

  • 13.1 OVERVIEW 99
  • 13.2 MAMMALIAN CELLS 101
  • 13.3 PLANTS 102
  • 13.4 FUNGI 103
  • 13.5 VIRUS 104
  • 13.6 BACTERIA 105

14 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION 106

  • 14.1 OVERVIEW 107
  • 14.2 IN VITRO APPLICATION 109
    • 14.2.1 IN VIVO APPLICATION 111
    • 14.2.2 BIOPRODUCTION 112
    • 14.2.3 OTHERS 112
    • 14.2.4 SYNTHETIC BIOLOGY 113
    • 14.2.5 AGRICULTURE 113
    • 14.2.6 OTHERS 113

15 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER 114

  • 15.1 OVERVIEW 115
  • 15.2 BIOPHARMA 118
  • 15.3 CROS 118
  • 15.4 CMOS/CDMOS 119
  • 15.5 ACADEMIA 120
  • 15.6 HOSPITALS 121
  • 15.7 CLINICAL LABS 122
  • 15.8 OTHERS 123

16 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL 124

  • 16.1 OVERVIEW 125
  • 16.2 DIRECT TENDER 128
  • 16.3 RETAIL SALES 129
  • 16.4 OTHERS 130

17 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION 131

  • 17.1 ASIA PACIFIC 132
    • 17.1.1 CHINA 137
    • 17.1.2 JAPAN 137
    • 17.1.3 INDIA 137
    • 17.1.4 AUSTRALIA 137
    • 17.1.5 SOUTH KOREA 137
    • 17.1.6 SINGAPORE 137
    • 17.1.7 THAILAND 137
    • 17.1.8 MALAYSIA 137
    • 17.1.9 INDONESIA 137
    • 17.1.10 PHILIPPINES 137
    • 17.1.11 REST OF ASIA-PACIFIC 137

18 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE 138

  • 18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 138

19 SWOT ANALYSIS 139

20 COMPANY PROFILE 140

  • 20.1 THERMO FISHER SCIENTIFIC INC. 140
    • 20.1.1 COMPANY SNAPSHOT 140
    • 20.1.2 REVENUE ANALYSIS 140
    • 20.1.3 COMPANY SHARE ANALYSIS 141
    • 20.1.4 PRODUCT PORTFOLIO 141
    • 20.1.5 RECENT DEVELOPMENT 142
  • 20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 143
    • 20.2.1 COMPANY SNAPSHOT 143
    • 20.2.2 REVENUE ANALYSIS 143
    • 20.2.3 COMPANY SHARE ANALYSIS 144
    • 20.2.4 PRODUCT PORTFOLIO 144
    • 20.2.5 RECENT DEVELOPMENT 145
  • 20.3 PROMEGA CORPORATION 146
    • 20.3.1 COMPANY SNAPSHOT 146
    • 20.3.2 COMPANY SHARE ANALYSIS 146
    • 20.3.3 PRODUCT PORTFOLIO 147
    • 20.3.4 RECENT DEVELOPMENT 147
  • 20.4 TAKARA BIO INC. 148
    • 20.4.1 COMPANY SNAPSHOT 148
    • 20.4.2 REVENUE ANALYSIS 148
    • 20.4.3 COMPANY SHARE ANALYSIS 149
    • 20.4.4 PRODUCT PORTFOLIO 149
    • 20.4.5 RECENT DEVELOPMENT 149
  • 20.5 BIO-RAD LABORATORIES, INC. 150
    • 20.5.1 COMPANY SNAPSHOT 150
    • 20.5.2 REVENUE ANANLYSIS 150
    • 20.5.3 COMPANY SHARE ANALYSIS 151
    • 20.5.4 PRODUCT PORTFOLIO 151
    • 20.5.5 RECENT DEVELOPMENT 152
  • 20.6 ALTOGEN BIOSYSTEMS 153
    • 20.6.1 COMPANY SNAPSHOT 153
    • 20.6.2 PRODUCT PORTFOLIO 153
    • 20.6.3 RECENT DEVELOPMENT 154
  • 20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 155
    • 20.7.1 COMPANY SNAPSHOT 155
    • 20.7.2 PRODUCT PORTFOLIO 155
    • 20.7.3 RECENT DEVELOPMENT 155
  • 20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC) 156
    • 20.8.1 COMPANY SNAPSHOT 156
    • 20.8.2 REVENUE ANALYSIS 156
    • 20.8.3 PRODUCT PORTFOLIO 157
    • 20.8.4 RECENT DEVELOPMENT 157
  • 20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER) 158
    • 20.9.1 COMPANY SNAPSHOT 158
    • 20.9.2 PRODUCT PORTFOLIO 158
    • 20.9.3 RECENT DEVELOPMENT 158
  • 20.10 CYTIVA 159
    • 20.10.1 COMPANY SNAPSHOT 159
    • 20.10.2 PRODUCT PORTFOLIO 159
    • 20.10.3 RECENT DEVELOPMENT 159
  • 20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 160
    • 20.11.1 COMPANY SNAPSHOT 160
    • 20.11.2 REVENUE ANANLYSIS 160
    • 20.11.3 PRODUCT PORTFOLIO 161
    • 20.11.4 RECENT DEVELOPMENT 161
  • 20.12 GENLANTIS INC. 162
    • 20.12.1 COMPANY SNAPSHOT 162
    • 20.12.2 PRODUCT PORTFOLIO 162
    • 20.12.3 RECENT DEVELOPMENT 162
  • 20.13 GENO TECHNOLOGY INC., USA 163
    • 20.13.1 COMPANY SNAPSHOT 163
    • 20.13.2 PRODUCT PORTFOLIO 163
    • 20.13.3 RECENT DEVELOPMENT 163
  • 20.14 GINKGO BIOWORKS 164
    • 20.14.1 COMPANY SNAPSHOT 164
    • 20.14.2 PRODUCT PORTFOLIO 164
    • 20.14.3 RECENT DEVELOPMENTS 164
  • 20.15 LONZA 165
    • 20.15.1 COMPANY SNAPSHOT 165
    • 20.15.2 REVENUE ANANLYSIS 165
    • 20.15.3 PRODUCT PORTFOLIO 166
    • 20.15.4 RECENT DEVELOPMENT 166
  • 20.16 MAXCYTE, INC. 167
    • 20.16.1 COMPANY SNAPSHOT 167
    • 20.16.2 REVENUE ANALYSIS 167
    • 20.16.3 PRODUCT PORTFOLIO 168
    • 20.16.4 RECENT DEVELOPMENT 168
  • 20.17 MERCK KGAA 169
    • 20.17.1 COMPANY SNAPSHOT 169
    • 20.17.2 REVENUE ANALYSIS 169
    • 20.17.3 PRODUCT PORTFOLIO 170
    • 20.17.4 RECENT DEVELOPMENT 170
  • 20.18 MIRUS BIO LLC. 171
    • 20.18.1 COMPANY SNAPSHOT 171
    • 20.18.2 PRODUCT PORTFOLIO 171
    • 20.18.3 RECENT DEVELOPMENT 171
  • 20.19 ORIGENE TECHNOLOGIES, INC. 173
    • 20.19.1 COMPANY SNAPSHOT 173
    • 20.19.2 PRODUCT PORTFOLIO 173
    • 20.19.3 RECENT DEVELOPMENT 173
  • 20.20 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.) 174
    • 20.20.1 COMPANY SNAPSHOT 174
    • 20.20.2 REVENUE ANALYSIS 174
    • 20.20.3 PRODUCT PORTFOLIO 175
    • 20.20.4 RECENT DEVELOPMENT 175
  • 20.21 POLYPLUS TRANSFECTION 176
    • 20.21.1 COMPANY SNAPSHOT 176
    • 20.21.2 PRODUCT PORTFOLIO 176
    • 20.21.3 RECENT DEVELOPMENT 176
  • 20.22 R&D SYSTEMS, INC. 178
    • 20.22.1 COMPANY SNAPSHOT 178
    • 20.22.2 PRODUCT PORTFOLIO 178
    • 20.22.3 RECENT DEVELOPMENT 178
  • 20.23 SBS GENETECH 179
    • 20.23.1 COMPANY SNAPSHOT 179
    • 20.23.2 PRODUCT PORTFOLIO 179
    • 20.23.3 RECENT DEVELOPMENT 179
  • 20.24 SIGNAGEN LABORATORIES 180
    • 20.24.1 COMPANY SNAPSHOT 180
    • 20.24.2 PRODUCT PORTFOLIO 180
    • 20.24.3 RECENT DEVELOPMENT 180

21 QUESTIONNAIRE 182

22 RELATED REPORTS 187

LIST OF TABLES

  • TABLE 1 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND) 65
  • TABLE 2 ASIA-PACIFIC REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
  • TABLE 3 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
  • TABLE 4 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND) 72
  • TABLE 5 ASIA-PACIFIC RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
  • TABLE 6 ASIA-PACIFIC PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
  • TABLE 7 ASIA-PACIFIC CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
  • TABLE 8 ASIA-PACIFIC COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
  • TABLE 9 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 80
  • TABLE 10 ASIA-PACIFIC TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
  • TABLE 11 ASIA-PACIFIC STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
  • TABLE 12 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND) 86
  • TABLE 13 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
  • TABLE 14 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
  • TABLE 15 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND) 92
  • TABLE 16 ASIA-PACIFIC PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
  • TABLE 17 ASIA-PACIFIC SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 94
  • TABLE 18 ASIA-PACIFIC PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
  • TABLE 19 ASIA-PACIFIC DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
  • TABLE 20 ASIA-PACIFIC RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
  • TABLE 21 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
  • TABLE 22 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND) 101
  • TABLE 23 ASIA-PACIFIC MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
  • TABLE 24 ASIA-PACIFIC PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
  • TABLE 25 ASIA-PACIFIC FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
  • TABLE 26 ASIA-PACIFIC VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
  • TABLE 27 ASIA-PACIFIC BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
  • TABLE 28 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND) 109
  • TABLE 29 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
  • TABLE 30 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
  • TABLE 31 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
  • TABLE 32 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
  • TABLE 33 ASIA-PACIFIC APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND) 113
  • TABLE 34 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
  • TABLE 35 ASIA-PACIFIC BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 118
  • TABLE 36 ASIA-PACIFIC CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 119
  • TABLE 37 ASIA-PACIFIC CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 120
  • TABLE 38 ASIA-PACIFIC ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 121
  • TABLE 39 ASIA-PACIFIC HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
  • TABLE 40 ASIA-PACIFIC CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
  • TABLE 41 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
  • TABLE 42 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
  • TABLE 43 ASIA-PACIFIC DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 128
  • TABLE 44 ASIA-PACIFIC RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 129
  • TABLE 45 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 130

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 26
  • FIGURE 2 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION 29
  • FIGURE 3 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS 30
  • FIGURE 4 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 31
  • FIGURE 5 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS 31
  • FIGURE 6 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING 32
  • FIGURE 7 ASIA-PACIFIC TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS 33
  • FIGURE 8 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID 34
  • FIGURE 9 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID 35
  • FIGURE 10 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS 36
  • FIGURE 11 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 40
  • FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030 41
  • FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030 41
  • FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA 48
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET 50
  • FIGURE 16 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023 61
  • FIGURE 17 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND) 62
  • FIGURE 18 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030) 62
  • FIGURE 19 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE 63
  • FIGURE 20 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023 68
  • FIGURE 21 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND) 69
  • FIGURE 22 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030) 69
  • FIGURE 23 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE 70
  • FIGURE 24 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023 76
  • FIGURE 25 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND) 77
  • FIGURE 26 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030) 77
  • FIGURE 27 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE 78
  • FIGURE 28 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022 82
  • FIGURE 29 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND) 83
  • FIGURE 30 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030) 83
  • FIGURE 31 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE 84
  • FIGURE 32 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022 88
  • FIGURE 33 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND) 89
  • FIGURE 34 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030) 89
  • FIGURE 35 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE 90
  • FIGURE 36 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022 97
  • FIGURE 37 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND) 98
  • FIGURE 38 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030) 98
  • FIGURE 39 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE 99
  • FIGURE 40 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022 105
  • FIGURE 41 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND) 106
  • FIGURE 42 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030) 106
  • FIGURE 43 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE 107
  • FIGURE 44 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022 113
  • FIGURE 45 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND) 114
  • FIGURE 46 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030) 114
  • FIGURE 47 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE 115
  • FIGURE 48 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022 123
  • FIGURE 49 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 124
  • FIGURE 50 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 124
  • FIGURE 51 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 125
  • FIGURE 52 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 131
  • FIGURE 53 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 133
  • FIGURE 54 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 133
  • FIGURE 55 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030) 134
  • FIGURE 56 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 134
  • FIGURE 57 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 136
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!